# OnCo record st-1898 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/st-1898/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "st-1898" ;
  schema:name "ST-1898"@en ;
  schema:alternateName "ACC-1898"@en ;
  schema:description "ST-1898 is an experimental small molecule, multi-target tyrosine kinase inhibitor from Beijing Scitech-Mq Pharmaceuticals, in phase 2 trials for unresectable or metastatic melanoma, advanced renal cell carcinoma and radioiodine-refractory differentiated thyroid cancer and other cancers."@en ;
  schema:url <https://onco.cc/drugs/st-1898/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/api/v2/studies/NCT06127238>, <https://clinicaltrials.gov/api/v2/studies/NCT06359847>, <https://clinicaltrials.gov/api/v2/studies/NCT07252661>, <https://clinicaltrials.gov/search?intr=ST-1898> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Small molecule (oral tablet), multi-target tyrosine kinase inhibitor" ;
  onco:cancers <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/rcc/>, <https://onco.cc/cancers/thyroid/>, <https://onco.cc/cancers/hcc/>, <https://onco.cc/cancers/medullary-thyroid-cancer/>, <https://onco.cc/cancers/gastric/> ;
  onco:targets <https://onco.cc/targets/met/>, <https://onco.cc/targets/axl/>, <https://onco.cc/targets/pdgfra/>, <https://onco.cc/targets/ret/>, <https://onco.cc/targets/kit/> ;
  onco:companies <https://onco.cc/companies/beijing-scitech-mq-pharmaceuticals/>, <https://onco.cc/companies/accsalus-biosciences/> ;
  onco:trials <https://onco.cc/trials/nct06359860/>, <https://onco.cc/trials/nct06127238/>, <https://onco.cc/trials/nct06359847/>, <https://onco.cc/trials/nct07252661/> .